Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05071963 · ClinicalTrials.gov registry record
INSPIRE Pipeline™ Shield Post Approval Study
A clinical trial of Intracranial Aneurysm, sponsored by Medtronic Neurovascular Clinical Affairs.
- Active
- Registry status
- 246
- Enrollment target
- 16
- Study locations
NCT05071963: Active study of Intracranial Aneurysm, sponsored by Medtronic Neurovascular Clinical Affairs.
NCT05071963 is a study of Intracranial Aneurysm that is active but no longer recruiting, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 246 participants, below the 9,179-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower). The trial reports 16 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05071963, a study of Intracranial Aneurysm, is active but no longer recruiting, sponsored by Medtronic Neurovascular Clinical Affairs.
- ACTIVE NOT RECRUITING
- Registry status
- 246 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pipeline™ Shield Device") in a real-world post approval setting within the United States.
Primary Outcome
Incidence at 1-year post-procedure of complete occlusion of the target aneurysm, significant parent artery stenosis ≤ 50%, and no retreatment of the target aneurysm.
Conditions Studied
Interventions
- DEVICE Treatment of Intracranial Aneurysms
Study Locations (16)
New York
- NYU Langone Medical Center - New York
- Montefiore Medical Center - New York
Pennsylvania
- Geisinger Medical Center - Danville
- Hospital of the University of Pennsylvania - Philadelphia
Alabama
- University of Alabama at Birmingham - Birmingham
Connecticut
- Yale New Haven Hospital - New Haven
Florida
- Baptist Medical Center Jacksonville - Jacksonville
Georgia
- Emory University Hospital - Atlanta
Illinois
- Endeavor Health - Evanston Hospital - Evanston
Kentucky
- Norton Healthcare - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2021-12-20 |
| Est. Completion | 2028-04 |
What the registry record for NCT05071963 still lists
NCT05071963 is an observational study that tracks outcomes without assigning an intervention. The registered 246 participants enrollment target is mid-sized for trials with a published cap, below the 9,179-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Treatment of Intracranial Aneurysms is the first listed.
NCT05071963 lists 16 locations in 14 states (New York, Pennsylvania, Alabama).
Frequently Asked Questions
What is clinical trial NCT05071963 about?
NCT05071963 is a clinical study titled "INSPIRE Pipeline™ Shield Post Approval Study". The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pip...
What is the current status of trial NCT05071963?
This trial is currently active not recruiting. The enrollment target is 246 participants. The study started on 2021-12-20. Estimated completion is 2028-04.
What conditions does trial NCT05071963 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
What interventions are being tested in trial NCT05071963?
The interventions under investigation include: Treatment of Intracranial Aneurysms (DEVICE).
Who is sponsoring clinical trial NCT05071963?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05071963 being conducted?
This trial has 16 study locations across Alabama, Connecticut, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05071963's enrollment target sits among peer trials
246 11th of 14 higher than 4 of 14 other Intracranial Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracranial Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Product Surveillance Registry
RECRUITING
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
-
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
RECRUITING
-
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
RECRUITING
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04973605 · 246 participants · Phase 1
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- NCT06395168 · 246 participants · NA
Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination
- NCT07048769 · 246 participants · Phase 4
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
- NCT07176650 · 246 participants · Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI